The Company’s Platinum ® line of instruments enables Next-Gen Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing ...

Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS ... With an installed base of over 25,000 sequencing instruments, including more than 21,600 active units ...

Quantum-Si, the pioneer in Next-Generation Protein Sequencing ... combined with the benchtop instrument Platinum™ to produce single-molecule peptide sequencing data. Presenter: Winston Timp ...

Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS ... With an installed base of over 25,000 sequencing instruments, including more than 21,600 active units as of ...

Quantum-Si's next-gen protein sequencing tech and growth partnerships show promise, but high costs, financial risks, and ...

whole-transcriptome sequencing, and epigenetic analysis. The NovaSeq X Plus instrument is now available and ready for submissions! The 2-channel chemistry, patterned flow-cells are best for large ...

The Africa Centres for Disease Control and Prevention (Africa CDC) and Illumina (NASDAQ: ILMN), a global leader in sequencing technol ...

Singular Genomics Systems (NASDAQ:OMIC – Get Free Report) will likely be issuing its quarterly earnings data after the market ...

Discover how automated liquid handling integration is revolutionizing NGS library preparation in genomic workflows.

including next-generation sequencing (NGS) platforms, reagents, and training support. As a part of this association, additional sequencing instruments and reagents will be provided to around 25 ...